0000000001183374

AUTHOR

Wim E Hennink

showing 2 related works from this author

Assessing the Effects of VEGF Releasing Microspheres on the Angiogenic and Foreign Body Response to a 3D Printed Silicone-Based Macroencapsulation De…

2021

Macroencapsulation systems have been developed to improve islet cell transplantation but can induce a foreign body response (FBR). The development of neovascularization adjacent to the device is vital for the survival of encapsulated islets and is a limitation for long-term device success. Previously we developed additive manufactured multi-scale porosity implants, which demonstrated a 2.5-fold increase in tissue vascularity and integration surrounding the implant when compared to a non-textured implant. In parallel to this, we have developed poly(ε-caprolactone-PEG-ε-caprolactone)-b-poly(L-lactide) multiblock copolymer microspheres containing VEGF, which exhibited continued release of bioa…

RS1-441angiogenesisPharmacy and materia medicadiabetesmedical devicemulti-scale porositydiabetes; prevascularization; drug delivery; VEGF; medical device; multi-scale porosity; angiogenesisSettore BIO/10 - Biochimicadrug deliveryPharmaceutical ScienceprevascularizationVEGFArticlePharmaceutics
researchProduct

Vascular Endothelial Growth Factor-Releasing Microspheres Based on Poly(ε-Caprolactone-PEG-ε-Caprolactone)-b-Poly(L-Lactide) Multiblock Copolymers In…

2020

Pancreatic islet transplantation is a promising advanced therapy that has been used to treat patients suffering from diabetes type 1. Traditionally, pancreatic islets are infused via the portal vein, which is subsequently intended to engraft in the liver. Severe immunosuppressive treatments are necessary, however, to prevent rejection of the transplanted islets. Novel approaches therefore have focused on encapsulation of the islets in biomaterial implants which can protect the islets and offer an organ-like environment. Vascularization of the device’s surface is a prerequisite for the survival and proper func- tioning of transplanted pancreatic islets. We are pursuing a prevascularization s…

Vascular Endothelial Growth Factor APDMS implantsTime FactorsDrug CompoundingPolyestersPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyPolyethylene Glycols03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePEG ratioHyaluronic acidHuman Umbilical Vein Endothelial CellsmedicineHumansDimethylpolysiloxanesHyaluronic Aciddiabetes type 1Cells CulturedCell Proliferationmultiblock copolymersDrug ImplantsDrug CarriersPancreatic isletsartificial pancreasBiomaterial021001 nanoscience & nanotechnologyControlled releaseVEGFMicrospheres3. Good healthVascular endothelial growth factorDrug Liberationmedicine.anatomical_structurechemistryPrinting Three-DimensionalAngiogenesis Inducing AgentsPancreatic islet transplantationcontrolled release PDMS implants VEGF multiblock copolymers diabetes type 1 artificial pancreas0210 nano-technologycontrolled releaseCaprolactoneBiomedical engineering
researchProduct